CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 8-K Event Regulation FD disclosure · Other events
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Executive or director change
- 4 Grant or award SVP, Bioservices acquired 15,000 shares (grant or award)
- 4 Grant or award EVP, Ext Aff, GC, Corp Sec acquired 15,000 shares (grant or award)
- 8-K Event Executive or director change
- 4 Shares withheld for taxes SVP, Products Business gave up 85 shares (to pay taxes)
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure · Other events
- 4 Shares withheld for taxes EVP, Ext Aff, GC, Corp Sec gave up 2,376 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Products Business gave up 464 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 1,249 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 2,733 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Bioservices gave up 1,167 shares (to pay taxes)
- SC 13G/A Stake Amended Statement of Ownership
Page 11 of 87 · 1,733 filings